NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Pulse Biosciences, Inc. PLSE
11 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$350,000
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-74.4%
Net margin · FY25
-20794.6%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 350,000.00
Revenue, FY2025 · full 11-year series below
Revenue
Net income
The company lost 20795 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-74.4%
Return on equity, FY2025
ROE
Operating margin-21982.6%
Net margin-20794.6%
Return on assets-64.1%
Each USD of equity lost 74 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−20.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2025
Change, 5 years+165.5%
Change, 10 years—
The share count grew 166% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 94.5M
total assets, end of FY2025
Total assetsUSD 94.5M
EquityUSD 80.7M
CashUSD 80.7M
Current ratio10.53×
Equity funds 85% of total assets.
History
11 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
·
·
·
·
·
Operating income $B
−0.1
−0.1
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.1
−0.1
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
·
·
·
·
−0.0
Net income $B
−0.1
−0.1
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
·
·
·
·
−2.28
−2.14
−2.26
−2.20
−1.73
−0.86
−0.37
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
ROE %
−74.4
−67.3
−200.5
−349.9
−217.3
−185.9
−96.8
−66.8
−71.7
−48.9
−20.6
Shares out B
0.07
0.07
0.06
0.04
0.03
0.03
0.02
0.02
0.02
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
33 of 33
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed